Celldex Therapeutics buy BiotechBee
Start price
07.09.22
/
80%
€29.80
Target price
31.12.25
€50.00
Performance (%)
-18.12%
End price
14.12.24
€24.40
Summary
This prediction ended on 14.12.24 with a price of €24.40. The prediction for Celldex Therapeutics disappointed with a performance of -18.12%. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celldex Therapeutics | -9.735% | -9.735% | -15.702% | -48.974% |
| iShares Core DAX® | -1.553% | -0.123% | 12.654% | 57.846% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.546% | 93.736% |
| iShares Nikkei 225® | 1.640% | 5.468% | 17.939% | 51.788% |
| iShares S&P 500 | 0.114% | -0.217% | 1.586% | 61.648% |
According to BiotechBee what are the pros and cons of Celldex Therapeutics for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Celldex Therapeutics diskutieren
Buy mit Kursziel 50,0